At a glance
ClinicalIndex Comparison RecordN/ACompleted· 65 enrolled
Drug / intervention
AqueSys XEN 45 Glaucoma Implantdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Multicenter Clinical Trial Designed to Evaluate the Safety and Performance of the AqueSys XEN 45 Glaucoma Implant in Subjects With Refractory Glaucoma
In Brief
A clinical study evaluating AqueSys XEN 45 Glaucoma Implant for Glaucoma and Glaucoma, Open Angle. Completed, enrolled 65 participants across 12 sites.
Detailed Summary
To establish the safety and performance of the AqueSys XEN 45 Glaucoma Implant in eyes with refractory glaucoma.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma, Glaucoma, Open Angle
CountriesUnited States
CollaboratorsAllergan
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2013
First PostedJan 2014
Primary CompletionFeb 2016
Study CompletionAug 2016
TodayJul 2026
First PostedJan 15, 2014
Enrollment StartJan 1, 2013
Primary CompletionFeb 1, 2016
Study CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 12.5 years ago
Interventions
AqueSys XEN 45 Glaucoma Implantdevice
Placement of the AqueSys XEN 45 Glaucoma Implant in the study eye